Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
488 studies found for:    "Sickle cell anemia"
Show Display Options
RSS Create an RSS feed from your search for:
"Sickle cell anemia"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Hydroxyurea in Young Children With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Drug: hydroxyurea
2 Completed Exercise Capacity in Pediatric Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention:
3 Recruiting Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention:
4 Completed The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Drug: Paludrine + Folic Acid;   Dietary Supplement: Paludrine + Folic Acid + Jobelyn
5 Completed Adherence to Hydroxyurea in Children With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Behavioral: Blood smear education;   Other: standard education
6 Not yet recruiting Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Drug: Ilaris, Canakinumab;   Drug: Placebo
7 Completed Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Drug: Hydroxyurea
8 Suspended Study of Beet Juice for Patients With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Drug: beet juice (Unbeetable)
9 Completed Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Drug: Hydroxyurea;   Drug: L-Arginine;   Drug: Sildenafil
10 Completed Sickle Cell Disease: A Retrospective Chart Review
Condition: Sickle Cell Anemia
Intervention:
11 Completed Carbon Monoxide Measurement to Screen for Sickle Cell Disease
Condition: Sickle Cell Anemia
Interventions: Device: End-tidal Carbon Monoxide Subjects;   Device: End-tidal Carbon Monoxide Controls
12 Terminated Risk-based Therapy for Sickle Cell Anemia: A Feasibility Study
Condition: Sickle Cell Anemia
Intervention: Drug: Hydroxyurea
13 Recruiting A Phase II Trial of Regadenoson in Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Drug: Regadenoson;   Drug: Placebo
14 Completed Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Dietary Supplement: Gum Arabic
15 Completed Study of Ventilatory Mechanics in Patients With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention:
16 Completed Pharmacokinetics (PK) of Liquid Hydroxyurea in Pediatric Patients With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention: Drug: Hydroxyurea
17 Recruiting SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Drug: Hydroxyurea;   Procedure: TCD examination
18 Recruiting Microvascular Blood Flow in Sickle Cell Anemia
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Interventions: Drug: regadenoson infusion with contrast-enhanced ultrasound;   Procedure: contrast-enhanced ultrasound
19 Completed
Has Results
Prasugrel Versus Placebo in Adult Sickle Cell Disease
Condition: Sickle Cell Anemia
Interventions: Drug: Prasugrel;   Drug: Placebo
20 Completed A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Interventions: Drug: Low Dose ICA-17043;   Drug: High dose ICA-17043;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.